+

WO2008133573A1 - Huile marine enrichie en acide gras polyinsaturé (pufa), comprenant l'acide eicosapentaénoïque (epa) et l'acide docosahexaénoïque (dha) et son procédé de fabrication - Google Patents

Huile marine enrichie en acide gras polyinsaturé (pufa), comprenant l'acide eicosapentaénoïque (epa) et l'acide docosahexaénoïque (dha) et son procédé de fabrication Download PDF

Info

Publication number
WO2008133573A1
WO2008133573A1 PCT/SE2008/000290 SE2008000290W WO2008133573A1 WO 2008133573 A1 WO2008133573 A1 WO 2008133573A1 SE 2008000290 W SE2008000290 W SE 2008000290W WO 2008133573 A1 WO2008133573 A1 WO 2008133573A1
Authority
WO
WIPO (PCT)
Prior art keywords
mol
acid
oil
dha
epa
Prior art date
Application number
PCT/SE2008/000290
Other languages
English (en)
Inventor
Patrick Adlercreutz
Ann-Marie Lyberg
Original Assignee
Patrick Adlercreutz
Ann-Marie Lyberg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Patrick Adlercreutz, Ann-Marie Lyberg filed Critical Patrick Adlercreutz
Priority to EP08741864A priority Critical patent/EP2147088A4/fr
Priority to CA002685272A priority patent/CA2685272A1/fr
Publication of WO2008133573A1 publication Critical patent/WO2008133573A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11C—FATTY ACIDS FROM FATS, OILS OR WAXES; CANDLES; FATS, OILS OR FATTY ACIDS BY CHEMICAL MODIFICATION OF FATS, OILS, OR FATTY ACIDS OBTAINED THEREFROM
    • C11C3/00—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom
    • C11C3/003—Fats, oils, or fatty acids by chemical modification of fats, oils, or fatty acids obtained therefrom by esterification of fatty acids with alcohols

Definitions

  • a polyunsaturated fatty acid (PUFA) enriched marine oil comprising eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) , and a process of production thereof
  • PUFA polyunsaturated fatty acid
  • EPA eicosapentaenoic acid
  • DHA docosahexaenoic acid
  • the invention relates to a PUFA enriched marine oil being substantially free from heavy metals, PCB and dioxins comprising at least 40 mol % eicosapentaenoic acid and docosahexaenoic acid and at least 50 mol % of mono and diglycerides as well as a method to produce such a PUFA enriched marine oil.
  • n-3 fatty acids have well documented positive health effects.
  • the most important fatty acids in this group are eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA).
  • EPA eicosapentaenoic acid
  • DHA docosahexaenoic acid
  • the dominating source of these fatty acids is various kinds of marine oils. Large efforts have been made to enrich EPA and DFIA from marine oils to obtain more concentrated products for use as food supplements or food ingredients. Most commonly the EPA and DHA containing triglycerides from the marine oil are hydrolysed to free fatty acids, followed by fractionation of the fatty acids using urea as complexation agent.
  • lipases More recently, the fatty acid specificity of lipases has been utilised to enrich EPA and/or DHA from marine oils. Most lipases have an ability to discriminate against the n-3 fatty acids and especially docosahexaenoic acid (DHA). Therefore lipases are utilised for enrichment of DHA and eicosapentaenoic acid (EPA) in marine oils, in free fatty acids or in simple esters of fatty acids. Furthermore, the lipases are able to operate at mild conditions, which is preferable since EPA and DHA are prone to oxidation. The choice of lipase and raw material depends on the desired lipid structure and ratio of EPA and DHA in the final product.
  • DHA docosahexaenoic acid
  • EPA eicosapentaenoic acid
  • the fatty acid specificity of the lipase should also be considered. If the fatty acids are located in triglycerides, the regiospecificity and triglyceride specificity also have an effect on the enrichment. Thus the positional distribution of the fatty acids and the glyceride molecule structure may have an impact on the ability of the lipase to enrich DHA and/or EPA in either the substrate or product and a product containing DHA and EPA as mono and di-glycerides will give rise to additional health benefits as well as emulsifying properties.
  • EPA and/or DHA of marine origin have been concentrated by different strategies using lipases. Most lipases discriminate against DHA more than against EPA such as Candida rugosa (formerly Candida cylindraced) and Rhizomucor miehei (Mukherjee et al. 1993). Nevertheless, there are lipases that discriminate against EPA more than against DHA such as porcine pancreas, Chromobacterium viscosum, Pseudomonas sp., Pseudomonas cepacia and Pseudomonas fluorescens (Breivik et al. 1997, Halldorsson et al. 2004, Mukherjee et al. 1993).
  • the lipase from Rhizomucor miehei was utilised for enrichment of DHA in free fatty acid from fish oil by esterification of the oil with butanol or glycerol (Halldorsson et al. 2003, Hills et al. 1990).
  • Another approach for concentrating both DHA and EPA in the free fatty acids was to esterify free fatty acids from marine origin with glycerol catalysed by one of the lipases from Pseudomonas sp., Pseudomonas fluoresceins, Thermomyces lanuginosus (formerly Humicula lanuginosa) or Rhizopus oryzae (Haraldsson et al. 2000).
  • Enrichment of both DHA and EPA in the glyceride fraction was obtained by ethanolysis or hydrolysis of fish oil catalysed by the lipase from Pseudomonas sp., Pseudomonas fluorescens, Geotrichum candidum (Breivik and Haraldsson 1995, Breivik et al. 1997, Haraldsson et al. 1997).
  • US 5945318 disclose a method in which a number of different lipases have been evaluated. Many of the lipases showed a low or no selectivity between different fatty acids. None of the lipases was immobilized.
  • EPA and DHA in the final product are ethyl esters and not mono-and di-glycerides. Examples of such method are disclosed in WO 2004043894 and Liang et al., 2000).
  • EPA and DHA containing products available for use as food supplements and food ingredients have the fatty acids as free fatty acids, simple esters (methyl or ethyl), as triglycerides and recently also as phospholipids. Most products contain more EPA than DHA.
  • the product of the present invention contains EPA and DHA mainly as di- and mono-glycerides, with additional health benefits as well as emulsifying properties, useful for some applications. Furthermore the product of the present invention contains more DHA than EPA, thus strengthening the specific health benefits of DHA. In this product, the positive effects of DHA and diglycerides are thus combined in a new way.
  • the invention relates to a PUFA enriched marine oil being substantially free from heavy metals, PCB and dioxins comprising at least 40 mol % eicosapentaenoic acid and docosahexaenoic acid and at least 50 mol % of mono and diglycerides.
  • an improved oil is available providing EPA and DHA mainly as di- and mono-glycerides, with additional health benefits as well as emulsifying properties. Furthermore the product of the present invention contains more DHA than EPA, thus strengthening the specific health benefits of DHA.
  • the invention also relates to a method of treating a marine oil having an eicosapentaenoic acid and docosahexaenoic acid content of at least 25 mol % comprising the steps of; providing an immobilised lipase, transesterifying said oil with a C1-C6 alcohol in the presence of said immobilised lipase and obtaining a product with EPA and DHA enriched in the glyceride fraction and a large part of the other fatty acid being in the form of esters of the alcohol used or as free fatty acids, removal of simple fatty acid esters and free fatty acids by distillation and obtaining a PUFA enriched marine oil being substantially free from heavy metals, PCB and dioxins comprising at least 40 mol % eicosapentaenoic acid and docosahexaenoic acid and at least 50 mol % of mono and diglycerides.
  • FIG 1 shows Mol% DHA in the glyceride fraction (TG + DG + MG) against loss of DHA from this fraction during ethanolysis of squid oil catalysed by RM, TL, PC and PF.
  • FIG 2 shows the reaction profile for the lipase from Thermomyces lanuginosus.
  • FIG 3 shows Mol% EPA in the glyceride fraction (TG + DG + MG) against loss of EPA from this fraction during ethanolysis of squid oil catalysed by RM, TL, PC and PF.
  • emulsifying properties is intended to mean that emulsions can be formed easily when oil and water are vigorously mixed.
  • fatty acid compositions are expressed using the term "mol %".
  • One mol % of fatty acid X means that 1 % of the fatty acid residues in that fraction is fatty acid X.
  • mol % Contents of different lipid classes (triglycerides, diglycerides, monoglycerides, free fatty acids and fatty acid ethyl esters) are expressed as mol %.
  • One mol % diglycerides means that the number of moles of diglycerides constitutes 1 % of the total number of moles of the different lipid classes.
  • the term "substantially free from” is intended to mean that the analysed values of contaminants are far below the limits set by the EU Commission according to heavy metals, PCB:s and dioxins in fish oil. ( ⁇ 0.1 ppm of each one of the elements: arsenic, cadmium, mercury and lead.)
  • PUFA polyunsaturated fatty acids
  • DHA docosahexaenoic acid
  • EPA eicosapentaenoic acid
  • OIL EXTRACT The invention relates to an improved PUFA enriched marine oil being substantially free from heavy metals, PCB and dioxins comprising at least 40 mol % eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) and at least 50 mol % of mono and diglycerides.
  • Said invented marine oil having improved properties such as having emulsifying properties which enables the possibility to form emulsions with water rich components to form dressings, sauces, desserts, doughs, dairy drinks, fruit and vegetable based drinks and many other kinds of food.
  • the content of eicosapentaenoic acid and docosahexaenoic acid in the oil extract may be at least or equal to 40 mol % and the content of the mono and diglycerides at least or equal to 60 mol %.
  • Other examples are at least 45 mol % EPA + DHA and at least 55 mol % mono and diglycerides or 50 mol % EPA + DHA and 50 % mono and diglycerides.
  • the ratio between eicosapentaenoic acid and docosahexaenoic acid may be lower than 1 and the molar ratio between mono and diglycerides may be lower than 1.
  • the content of the mono and diglycerides mat be at least 50, 60, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75 ,76, 77, 78, 79, 80 mol %or even higher.
  • the content of the triglycerides may be from about 5 to about 30 %, such as 5-25, 5-20, 5-15 mol %. Specific examples are 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29 or 30 mol %.
  • the oil extract may be obtained from any suitable marine oil source such as be selected from the group consisting of different kinds of fish, algae, crustaceans and for example one suitable source is squid.
  • the invention relates to a method of treating a marine oil having an eicosapentaenoic acid and docosahexaenoic acid content of at least 25 % comprising the steps of; providing an immobilised lipase or a mixture of lipases, transesterifying said oil with a C1-C6 alcohol in the presence of said immobilised lipase and obtaining a product in which EPA and DHA are enriched in the glyceride fraction and a large part of the other fatty acids are present as esters of the alcohol used or as free fatty acids.
  • a PUFA-enriched marine oil substantially free from heavy metals, PCB and dioxins comprising at least 40 mol % eicosapentaenoic acid and docosahexaenoic acid and an at least 50 mol % of mono and diglycerides.
  • Immobilisation of the lipase or lipases provides several advantages such as higher activity and stability of the lipases.
  • Suitable support materials are porous inorganic or organic materials, with silica and polypropylene as a couple of examples.
  • Some immobilised lipases are commercially available, such as Lipozym RM IM from Novozymes, Denmark.
  • lipases examples include those from Thermomyces lanuginosus, Pseudomonas cepacia, Pseudomonas fluorescens and Rhizomucor miehei.
  • One suitable lipase being the one from Thermomyces lanuginosus, which can be obtained from Novozymes, Denmark or Sigma-Aldrich, St Louis, MO, USA.
  • the transesterification step may be done with an alcohol or a mixture of alcohols such as methanol, ethanol, propanol, butanol, pentanol or hexanol. During the transesterification it is of importance to protect the unsaturated fatty acids from oxidation. This may be done by carrying out the reaction under nitrogen.
  • the concentration of the marine oil extract may be done by distillation in one or several distillation steps, whereby the relatively volatile fatty acid esters and free fatty acids can be removed from the less volatile residual glyceride mixture. In the distillation step potential volatile contaminants such as PCB and dioxins are efficiently removed from the glyceride mixture.
  • the distillation is preferably carried out at low temperature and pressure.
  • the invented process is especially adapted to the preparation of marine oil extracts as defined above having a specific combination and amount of mono- and diglycerides as well as EPA and DHA having healthy effects on the mammal, such as a human being.
  • Examples are intended to illustrate, but not to limit, the invention in any manner, shape, or form, either explicitly or implicitly.
  • Tridecanoic acid albumin from bovine serum and non-immobilised lipases from Rhizomucor miehei (RM), Thermomyces lanuginosus (TL), Pseudomonas cepacia (Amano lipase PS)(PC) and Pseudomonas fluorescens (Amano lipase)(PF) were bought from Sigma (St Louis, MO, USA). The squid oil was deodorized. Accurel MPlOOO, a polypropylene support for immobilisation, was obtained from Akzo (Obernburg, Germany).
  • the lipases were immobilised on the polypropylene support MPlOOO by adsorption.
  • the amount of lipase added during the immobilisation corresponded to a 40 mg protein/g support.
  • the lipase was dissolved in 20 mM sodium phosphate buffer (pH 6). The solution was centrifuged and the supernatant was added to the MPlOOO, which was prewetted with ethanol (3 ml/g preparation). The mixture containing both enzyme and support was shaken overnight at room temperature. Then the enzyme preparation was filtered and washed with sodium phosphate buffer (20 mM, pH 6). To the enzyme preparation 1 ml sodium phosphate buffer (200 mM, pH I)Ig preparation was added and this preparation was dried under reduced pressure overnight.
  • the protein loading of the lipase preparations was determined to 22 mg protein/g support for Rhizomucor miehei, 33 mg protein/g support for Thermomyces lanuginosus, 19 mg protein/g support for Pseudomonas cepacia and 6 mg protein/g support for Pseudomonas fluorescens.
  • TG Triglycerides
  • DG diglycerides
  • MG monoglycerides
  • FFA free fatty acids
  • the TLC plate was sprayed with 0.1% 2,7-dichlorofluorescein in ethanol.
  • the bands of TG (start samples only), DG, MG and FFA were scraped off and placed in glass tubes for fatty acid analysis.
  • Triglycerides, diglycerides and monoglycerides were separately methylated using sodium methoxide as reagent. Methylation of free fatty acids was carried out using sulphuric acid as catalyst. Ethyl esters from the TLC plates were extracted in cyclohexane. Fatty acids in the form of either methyl esters or ethyl esters were analysed using gas chromatography.
  • the response factors of the different fatty acid methyl esters were obtained from analysis of a standard mixture. These response factors were used to calculate the relative amounts of different fatty acids within a sample based on mol%. These data were compared with the internal standard (methyl tridecanoate) to determine the absolute amount ( ⁇ mol) of the fatty acids in the sample. Results
  • Ethanolysis of squid oil was catalysed by lipases from Rhizomucor miehei (RM), Thermomyces lanuginosus (TL), Pseudomonas cepacia (PC) and Pseudomonas fluoresceins (PF) in order to compare their ability to discriminate against EPA and DHA.
  • RM Rhizomucor miehei
  • TL Thermomyces lanuginosus
  • PC Pseudomonas cepacia
  • PF Pseudomonas fluoresceins
  • Fig. 1 shows the enrichment of DHA against the DHA loss for four lipases.
  • the lipase that obtained the highest DHA recovery during the enrichment of DHA was that from Thermomyces lanuginosus. After 24 hours of reaction the glyceride fraction contained 37 mol%, and 1.7 mol% of DHA was lost. An even higher enrichment after 24 hours of reaction was provided by the lipase from Rhizomucor miehei. However, this lipase also showed a considerable DHA loss (6.8 mol%). The lipase from Thermomyces lanuginosus was therefore considered the most suitable lipase for enrichment of DHA in the squid oil.
  • the reaction profile provided by the lipase from Thermomyces lanuginosus is shown in Fig. 2.
  • the triglycerides were converted to diglyceride at a high rate.
  • No DHA ethyl esters were formed during the first 1.5 hours.
  • the lipase from Thermomyces lanuginosus was chosen to catalyse ethanolysis in a larger scale.
  • Squid oil (500 g), ethanol (108 ml) and immobilised lipase from Thermomyces lanuginosus (13.9 g) were stirred with continuous nitrogen addition for 24 hours.
  • the DHA and EPA content of the glyceride fraction had reached 35 and 17 mol%, respectively.
  • the recovery of DHA was 97 mol% and the recovery of EPA was 79 mol%.
  • the dominating glyceride fraction was the diglycerides (Table T).
  • the reaction was stopped by filtering off the enzyme after which the ethanol was evaporated.
  • the ethyl esters were separated from the glyceride fraction after ethanolysis by using short path distillation (KD4, UIC GmbH, Alzenau-H ⁇ rstein, Germany). The distillation was first performed at 120 0 C, and the remaining part was distilled once more at 130°C. After the first distillation the distillate contained 167.6 g and the remainder 270.3 g. After the second distillation the distillate contained 6.1 g and the remainder (the final product) contained 243.1 g.
  • the reaction as well as the purification step was repeated and the result was a lipid composition in which there were at least 40 mo% EPA and DPA as well as at least 50 mol% of mono- and di-glycerides.

Landscapes

  • Chemical & Material Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Fats And Perfumes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

L'invention porte sur une huile marine enrichie en PUFA qui est sensiblement exempte de métaux lourds, PCB et dioxines, comprenant au moins 40 % en moles d'acide eicosapentaénoïque et d'acide docosahexaénoïque sous la forme telle qu'au moins 50 % en moles de mono- et diglycérides, ainsi que sur un procédé de fabrication d'une telle huile marine enrichie en PUFA.
PCT/SE2008/000290 2007-04-26 2008-04-25 Huile marine enrichie en acide gras polyinsaturé (pufa), comprenant l'acide eicosapentaénoïque (epa) et l'acide docosahexaénoïque (dha) et son procédé de fabrication WO2008133573A1 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
EP08741864A EP2147088A4 (fr) 2007-04-26 2008-04-25 Huile marine enrichie en acide gras polyinsaturé (pufa), comprenant l'acide eicosapentaénoïque (epa) et l'acide docosahexaénoïque (dha) et son procédé de fabrication
CA002685272A CA2685272A1 (fr) 2007-04-26 2008-04-25 Huile marine enrichie en acide gras polyinsature (pufa), comprenant l'acide eicosapentaenoique (epa) et l'acide docosahexaenoique (dha) et son procede de fabrication

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0701001-0 2007-04-26
SE0701001 2007-04-26

Publications (1)

Publication Number Publication Date
WO2008133573A1 true WO2008133573A1 (fr) 2008-11-06

Family

ID=39925913

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/SE2008/000290 WO2008133573A1 (fr) 2007-04-26 2008-04-25 Huile marine enrichie en acide gras polyinsaturé (pufa), comprenant l'acide eicosapentaénoïque (epa) et l'acide docosahexaénoïque (dha) et son procédé de fabrication

Country Status (3)

Country Link
EP (1) EP2147088A4 (fr)
CA (1) CA2685272A1 (fr)
WO (1) WO2008133573A1 (fr)

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010010365A1 (fr) * 2008-07-24 2010-01-28 Pharma Marine As Acides gras polyinsaturés pour améliorer la vision
WO2010010364A3 (fr) * 2008-07-24 2010-03-25 Pharma Marine As Procédé de purification d’huiles
CN101736044A (zh) * 2008-11-18 2010-06-16 浙江海洋学院 一种连续化酶促合成n-3PUFA甘油酯的方法
WO2012160442A1 (fr) * 2011-05-20 2012-11-29 Pharma Marine As Procédé pour améliorer les oméga-3 et éliminer les contaminants volatils simultanément
WO2013007315A1 (fr) 2011-07-14 2013-01-17 Soluciones Extractivas Alimentarias, S.L. Nouveau procédé de réduction des polluants dans les graisses et les huiles et leurs dérivés
US20130196393A1 (en) * 2010-06-25 2013-08-01 Epax As Process for separating polyunsaturated fatty acids from long chain unsaturated or less saturated fatty acids
US9050309B2 (en) 2012-01-06 2015-06-09 Omthera Pharmaceuticals, Inc. DPA-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form
JPWO2013172346A1 (ja) * 2012-05-14 2016-01-12 日本水産株式会社 環境汚染物質を低減させた高度不飽和脂肪酸又は高度不飽和脂肪酸エチルエステル及びその製造方法
JP2016502573A (ja) * 2012-11-02 2016-01-28 プロノヴァ・バイオファーマ・ノルゲ・アーエスＰｒｏｎｏｖａ ＢｉｏＰｈａｒｍａ Ｎｏｒｇｅ ＡＳ 油組成物からの好ましくない成分の除去
US9492545B2 (en) 2012-05-07 2016-11-15 Omthera Pharmaceuticals Inc. Compositions of statins and omega-3 fatty acids
US20160374977A1 (en) * 2015-06-26 2016-12-29 Pronova Biopharma Norge As Composition for Treatment of Mold
KR20170018825A (ko) * 2014-06-06 2017-02-20 마린 인그리디언츠, 엘엘씨 오메가-3 조성물, 제형 및 사용 방법
ITUB20153877A1 (it) * 2015-09-24 2017-03-24 Tiberio Bruzzese Metodo di purificazione di gliceridi di acidi grassi, composizioni che ne derivano, e loro uso
EP3165591A4 (fr) * 2014-07-02 2017-11-29 Nippon Suisan Kaisha, Ltd. Procédé de fabrication d'acides gras libres insaturés monovalents dérivés d'un produit de la mer ou de leurs esters d'alcool de basse qualité
CN111172210A (zh) * 2020-03-20 2020-05-19 江南大学 一种两步酶法制备富含花生四烯酸甘油酯的方法及其产品
CN111172211A (zh) * 2020-03-20 2020-05-19 江南大学 一种酶法制备富含鱼油n-3长链多不饱和脂肪酸甘油酯的方法及其产品
WO2022211017A1 (fr) * 2021-04-01 2022-10-06 花王株式会社 Composition d'huile/matière grasse

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023100A (en) * 1988-05-02 1991-06-11 Kabi Vitrum Ab Fish oil
US5945318A (en) * 1994-03-08 1999-08-31 Norsk Hydro A.S. Refining oil compositions
WO2004043894A1 (fr) * 2002-11-14 2004-05-27 Pronova Biocare As Esterification de petrole marin catalysee par des lipases
US20050256326A1 (en) * 2002-07-11 2005-11-17 Pronova Biocare As Process for decreasing environmental pollutants in an oil or a fat, a volatile environmental pollutants decreasing working fluid, a health supplement, and an animal feed product

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5935828A (en) * 1989-05-01 1999-08-10 Opta Food Ingredients, Inc. Enzymatic production of monoglycerides containing omega-3 unsaturated fatty acids

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5023100A (en) * 1988-05-02 1991-06-11 Kabi Vitrum Ab Fish oil
US5945318A (en) * 1994-03-08 1999-08-31 Norsk Hydro A.S. Refining oil compositions
US20050256326A1 (en) * 2002-07-11 2005-11-17 Pronova Biocare As Process for decreasing environmental pollutants in an oil or a fat, a volatile environmental pollutants decreasing working fluid, a health supplement, and an animal feed product
WO2004043894A1 (fr) * 2002-11-14 2004-05-27 Pronova Biocare As Esterification de petrole marin catalysee par des lipases

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
BREIVIK H. ET AL.: "Preparation of highly purified concentrates of eicosapentaenoic acid and docosahexaenoic acid", JAOCS, JOURNAL OF THE AMERICAN OIL CHEMISTS' SOCIETY, vol. 74, no. 11, 1997, pages 1425 - 1429, XP000736918 *
HARALDSSON G.G. ET AL.: "The preparation of concentrates of eicosapentaenoic acid and docosahexaenoic acid by lipase-catalyzed transesterification of fish oil with ethanol", JAOCS, JOURNAL OF THE AMERICAN OIL CHEMISTS' SOCIETY, vol. 74, no. 11, 1997, pages 1419 - 1424, XP000736917 *
LIANG J.-H. ET AL.: "Fractionation of squid visceral oil ethyl esters by short-path distillation", JAOCS, JOURNAL OF THE AMERICAN OIL CHEMISTS' SOCIETY, vol. 77, no. 7, 2000, pages 773 - 777, XP000959240 *
See also references of EP2147088A4 *
THE BROSCHURE: "Short path distillation in the fish oil industry", 1 September 2006 (2006-09-01), XP003023097 *

Cited By (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010010364A3 (fr) * 2008-07-24 2010-03-25 Pharma Marine As Procédé de purification d’huiles
WO2010010365A1 (fr) * 2008-07-24 2010-01-28 Pharma Marine As Acides gras polyinsaturés pour améliorer la vision
CN101736044A (zh) * 2008-11-18 2010-06-16 浙江海洋学院 一种连续化酶促合成n-3PUFA甘油酯的方法
US20130196393A1 (en) * 2010-06-25 2013-08-01 Epax As Process for separating polyunsaturated fatty acids from long chain unsaturated or less saturated fatty acids
US9476008B2 (en) 2010-06-25 2016-10-25 Epax As Process for separating polyunsaturated fatty acids from long chain unsaturated or less saturated fatty acids
WO2012160442A1 (fr) * 2011-05-20 2012-11-29 Pharma Marine As Procédé pour améliorer les oméga-3 et éliminer les contaminants volatils simultanément
WO2013007315A1 (fr) 2011-07-14 2013-01-17 Soluciones Extractivas Alimentarias, S.L. Nouveau procédé de réduction des polluants dans les graisses et les huiles et leurs dérivés
US9050309B2 (en) 2012-01-06 2015-06-09 Omthera Pharmaceuticals, Inc. DPA-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form
US9050308B2 (en) 2012-01-06 2015-06-09 Omthera Pharmaceuticals, Inc. DPA-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form
US10117844B2 (en) 2012-01-06 2018-11-06 Omthera Pharmaceuticals, Inc. DPA-enriched compositions of omega-3 polyunsaturated fatty acids in free acid form
US9492545B2 (en) 2012-05-07 2016-11-15 Omthera Pharmaceuticals Inc. Compositions of statins and omega-3 fatty acids
US10399922B2 (en) 2012-05-14 2019-09-03 Nippon Suisan Kaisha, Ltd. Highly unsaturated fatty acid or highly unsaturated fatty acid ethyl ester with reduced environmental pollutants, and method for producing same
US11603347B2 (en) 2012-05-14 2023-03-14 Nippon Suisan Kaisha, Ltd. Highly unsaturated fatty acid or highly unsaturated fatty acid ethyl ester with reduced environmental pollutants, and method for producing same
US11034643B2 (en) 2012-05-14 2021-06-15 Nippon Suisan Kaisha, Ltd. Highly unsaturated fatty acid or highly unsaturated fatty acid ethyl ester with reduced environmental pollutants, and method for producing same
US10399923B2 (en) 2012-05-14 2019-09-03 Nippon Suisan Kaisha, Ltd. Highly unsaturated fatty acid or highly unsaturated fatty acid ethyl ester with reduced environmental pollutants, and method for producing same
JPWO2013172346A1 (ja) * 2012-05-14 2016-01-12 日本水産株式会社 環境汚染物質を低減させた高度不飽和脂肪酸又は高度不飽和脂肪酸エチルエステル及びその製造方法
JP2016502573A (ja) * 2012-11-02 2016-01-28 プロノヴァ・バイオファーマ・ノルゲ・アーエスＰｒｏｎｏｖａ ＢｉｏＰｈａｒｍａ Ｎｏｒｇｅ ＡＳ 油組成物からの好ましくない成分の除去
US9675575B2 (en) 2014-06-06 2017-06-13 Marine Ingredients, Llc Omega-3 compositions, dosage forms, and methods of use
KR20170018825A (ko) * 2014-06-06 2017-02-20 마린 인그리디언츠, 엘엘씨 오메가-3 조성물, 제형 및 사용 방법
EP3151826A4 (fr) * 2014-06-06 2018-01-24 Marine Ingredients, LLC Compositions d'oméga -3, formes posologiques et procédés d'utilisation
US10034849B2 (en) 2014-06-06 2018-07-31 Marine Ingredients, Llc Omega-3 compositions, dosage forms, and methods of use
JP2017516811A (ja) * 2014-06-06 2017-06-22 マリン イングリーディエンツ， エルエルシー ω−３組成物、剤形および使用法
US10172819B2 (en) 2014-06-06 2019-01-08 Marine Ingredients, Llc Omega-3 compositions, dosage forms, and methods of use
KR102400958B1 (ko) * 2014-06-06 2022-05-20 마린 인그리디언츠, 엘엘씨 오메가-3 조성물, 제형 및 사용 방법
US11160777B2 (en) 2014-06-06 2021-11-02 Marine Ingredients, Llc Omega-3 compositions, dosage forms, and methods of use
EP3165591A4 (fr) * 2014-07-02 2017-11-29 Nippon Suisan Kaisha, Ltd. Procédé de fabrication d'acides gras libres insaturés monovalents dérivés d'un produit de la mer ou de leurs esters d'alcool de basse qualité
US10597606B2 (en) 2014-07-02 2020-03-24 Nippon Suisan Kaisha, Ltd. Production method of marine product-derived free monounsaturated fatty acids or lower alcohol esters thereof
US20160374977A1 (en) * 2015-06-26 2016-12-29 Pronova Biopharma Norge As Composition for Treatment of Mold
AU2016281819B2 (en) * 2015-06-26 2021-10-14 Pronova Biopharma Norge As Composition for treatment of NAFLD
WO2016207734A1 (fr) * 2015-06-26 2016-12-29 Pronova Biopharma Norge As Composition pour le traitement de la nafld
ITUB20153877A1 (it) * 2015-09-24 2017-03-24 Tiberio Bruzzese Metodo di purificazione di gliceridi di acidi grassi, composizioni che ne derivano, e loro uso
WO2017050666A1 (fr) * 2015-09-24 2017-03-30 Tiberio Bruzzese Procédé de purification de glycérides d'acide gras, compositions dérivées de ces derniers, et leur utilisation
CN111172211A (zh) * 2020-03-20 2020-05-19 江南大学 一种酶法制备富含鱼油n-3长链多不饱和脂肪酸甘油酯的方法及其产品
CN111172210A (zh) * 2020-03-20 2020-05-19 江南大学 一种两步酶法制备富含花生四烯酸甘油酯的方法及其产品
WO2022211017A1 (fr) * 2021-04-01 2022-10-06 花王株式会社 Composition d'huile/matière grasse

Also Published As

Publication number Publication date
CA2685272A1 (fr) 2008-11-06
EP2147088A1 (fr) 2010-01-27
EP2147088A4 (fr) 2010-05-05

Similar Documents

Publication Publication Date Title
WO2008133573A1 (fr) Huile marine enrichie en acide gras polyinsaturé (pufa), comprenant l'acide eicosapentaénoïque (epa) et l'acide docosahexaénoïque (dha) et son procédé de fabrication
CA2506537C (fr) Esterification de petrole marin catalysee par des lipases
EP0749468B1 (fr) Raffinage de compositions d'huile
KR100538480B1 (ko) 리파아제를 이용한 글리세리드의 제조방법
EP2585570B1 (fr) Procédé de séparation des acides gras polyinsaturés d'acides gras à chaîne longue insaturés ou moins saturés
JP2020513750A (ja) グリセリドの形態におけるｎ−３脂肪酸の酵素的濃縮
AU6680294A (en) Process for production of human milk fat replacers
Verdasco-Martín et al. Selective synthesis of partial glycerides of conjugated linoleic acids via modulation of the catalytic properties of lipases by immobilization on different supports
WO2012087153A1 (fr) Enrichissement d'huiles d'animaux marins en acides gras oméga 3 polyinsaturés par une hydrolyse catalysée par une lipase
Zhao et al. Preparation of highly purified pinolenic acid from pine nut oil using a combination of enzymatic esterification and urea complexation
EP3848466A1 (fr) Procédé de production de glycéride contenant un acide gras polyinsaturé au moyen d'une réaction d'hydrolyse par une lipase
US20080248187A1 (en) Mixture containing fatty acid glycerides
Li et al. Preparation of highly pure n-3 PUFA-enriched triacylglycerols by two-step enzymatic reactions combined with molecular Distillation
Lyberg et al. Lipase‐catalysed enrichment of DHA and EPA in acylglycerols resulting from squid oil ethanolysis
JP2020174570A (ja) 高度不飽和脂肪酸及び中鎖脂肪酸含有トリグリセリドの製造方法
Ma et al. Integrated production of biodiesel and concentration of polyunsaturated fatty acid in glycerides through effective enzymatic catalysis
Sitompul et al. Synthesis of Structured Triglycerides Based on Canarium Oil for Food Application.
KR102784785B1 (ko) 고정화 효소로 Lipozyme TL IM을 이용한 감마리놀렌산 고함유 트리글리세라이드 제조방법
Hernández-Martín et al. Enzymatic re-esterification of lower glycerides from soybean oil with conjugated linoleic acid (CLA)
Hernández‐Martín et al. Selective enzymatic synthesis of lower acylglycerols rich in polyunsaturated fatty acids
WO2010115764A2 (fr) Triglycérides à forte teneur en acides gras insaturés
EP1978101A1 (fr) Procédé d'enrichissement en acides gras polyinsaturés
Piazza et al. Lipase-catalyzed harvesting and/or enrichment of industrially and nutritionally important fatty acids

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08741864

Country of ref document: EP

Kind code of ref document: A1

WWE Wipo information: entry into national phase

Ref document number: 2685272

Country of ref document: CA

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2008741864

Country of ref document: EP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载